CVRX

CVRx, Inc.

Price Chart

Latest Quote

$4.95

+0.12 (+2.48%)

Current Price

Previous Close	$4.83
Open	$4.92
Day High	$5.00
Day Low	$4.85
Volume	283,379

Fetched: 2026-06-18T20:43:27

Stock Information

Shares Outstanding	26.54M
Total Debt	$59.40M
Cash Equivalents	$72.30M
Revenue	$59.07M
Net Income	$-52.66M
Sector	Healthcare
Industry	Medical Devices
Market Cap	$131.35M
EPS (TTM)	$-2.02
Exchange	NMS

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Enterprise Value	$118.44M
Sales	$59.07M
Income	$-52.66M
Book/sh	$1.10
Cash/sh	$2.72
Employees	223

Financial Ratios

Quick Ratio	8.58
Current Ratio	10.20
Debt/Eq	204.04

Returns & Margins

ROA	-27.25%
ROE	-106.96%
Gross Margin	86.18%
Operating Margin	-82.34%
Profit Margin	-89.14%

Ownership

Insider Ownership	9.55%
Institutional Ownership	63.58%
Insider & Institutional transactions data not available

Valuation Ratios

Forward P/E	-2.61
P/S	2.22
P/B	4.50

Analyst Data

Recommendation	buy
Target Price	$11.17

Technical Indicators

SMA20	$5.39
SMA50	$6.39
SMA200	$7.72
RSI	36.24
ATR	0.3430

Shares Float	18.33M
Short Float	10.27%
Short Ratio	5.23
Volatility	0.77
Rel Volume	1.14

Performance History

Week	+1.23%
Month	-17.64%
Quarter	-42.64%
6 Months	-40.50%
YTD	-30.28%
Year	-12.54%
3 Years	-66.96%
10 Years	-82.32%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-18	$4.95	293,200
2026-06-17	$4.83	241,400
2026-06-16	$4.87	101,000
2026-06-15	$4.98	90,200
2026-06-12	$5.03	264,400
2026-06-11	$4.89	474,900
2026-06-10	$4.83	445,500
2026-06-09	$5.20	401,700
2026-06-08	$5.40	242,000
2026-06-05	$5.38	234,800
2026-06-04	$5.88	310,400
2026-06-03	$5.39	284,100
2026-06-02	$5.43	238,300
2026-06-01	$5.43	262,600
2026-05-29	$5.58	162,500
2026-05-28	$5.63	332,300
2026-05-27	$5.78	189,800
2026-05-26	$6.08	124,100
2026-05-22	$6.11	245,900
2026-05-21	$6.07	222,900
2026-05-20	$6.06	252,800
2026-05-19	$6.01	296,100

About CVRx, Inc.

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

📰 Latest News

CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy

Zacks • 2026-05-18T16:32:00Z

Analysts Have Made A Financial Statement On CVRx, Inc.'s (NASDAQ:CVRX) First-Quarter Report

Simply Wall St. • 2026-05-15T10:39:29Z

Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX)

Zacks • 2026-05-13T13:35:03Z

CVRx Inc (CVRX) Q1 2026 Earnings Call Highlights: Strong U.S. Growth and Market Expansion Potential

GuruFocus.com • 2026-05-12T07:06:44Z

CVRx Q1 Earnings Call Highlights

MarketBeat • 2026-05-11T23:05:13Z

CVRx (CVRX) Reports Q1 Loss, Beats Revenue Estimates

Zacks • 2026-05-11T22:05:04Z

Pacific Biosciences of California (PACB) Reports Q1 Loss, Lags Revenue Estimates

Zacks • 2026-05-07T21:55:07Z

CVRx (CVRX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Zacks • 2026-05-01T13:55:02Z

CVRx Inc (CVRX) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions Amid ...

GuruFocus.com • 2026-02-16T01:01:18Z

Analysts Are Updating Their CVRx, Inc. (NASDAQ:CVRX) Estimates After Its Full-Year Results

Simply Wall St. • 2026-02-15T13:24:50Z

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Reconciled Cost Of Revenue	$8,311,000	$8,334,000	$6,256,000	$4,999,000
Cost Of Revenue	$8,311,000	$8,334,000	$6,256,000	$4,999,000
Total Revenue	$56,651,000	$51,292,000	$39,295,000	$22,469,000
Operating Revenue	$56,651,000	$51,292,000	$39,295,000	$22,469,000
Expenses
Interest Expense	$5,827,000	$4,397,000	$1,799,000	$165,000
Total Expenses	$107,916,000	$110,782,000	$82,398,000	$64,996,000
Other Income Expense	$3,768,000	$3,977,000	$3,850,000	$1,373,000
Other Non Operating Income Expenses	$3,768,000	$3,977,000	$3,850,000	$1,373,000
Net Non Operating Interest Income Expense	$-5,827,000	$-4,397,000	$-1,799,000	$-165,000
Interest Expense Non Operating	$5,827,000	$4,397,000	$1,799,000	$165,000
Operating Expense	$99,605,000	$102,448,000	$76,142,000	$59,997,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-53,306,000	$-59,965,000	$-41,199,000	$-41,428,000
Net Interest Income	$-5,827,000	$-4,397,000	$-1,799,000	$-165,000
Normalized Income	$-53,306,000	$-59,965,000	$-41,199,000	$-41,428,000
Net Income From Continuing And Discontinued Operation	$-53,306,000	$-59,965,000	$-41,199,000	$-41,428,000
Total Operating Income As Reported	$-51,265,000	$-59,490,000	$-43,103,000	$-42,527,000
Net Income Common Stockholders	$-53,306,000	$-59,965,000	$-41,199,000	$-41,428,000
Net Income	$-53,306,000	$-59,965,000	$-41,199,000	$-41,428,000
Net Income Including Noncontrolling Interests	$-53,306,000	$-59,965,000	$-41,199,000	$-41,428,000
Net Income Continuous Operations	$-53,306,000	$-59,965,000	$-41,199,000	$-41,428,000
Pretax Income	$-53,324,000	$-59,910,000	$-41,052,000	$-41,319,000
Operating Income	$-51,265,000	$-59,490,000	$-43,103,000	$-42,527,000
Gross Profit	$48,340,000	$42,958,000	$33,039,000	$17,470,000
Per Share
Diluted EPS	$-2.04	$-2.65	$-1.99	$-2.02
Basic EPS	$-2.04	$-2.65	$-1.99	$-2.02
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-46,741,000	$-54,894,000	$-38,731,000	$-40,742,000
Reconciled Depreciation	$756,000	$619,000	$522,000	$412,000
EBITDA (Bullshit earnings)	$-46,741,000	$-54,894,000	$-38,731,000	$-40,742,000
EBIT	$-47,497,000	$-55,513,000	$-39,253,000	$-41,154,000
Diluted Average Shares	$26,084,709	$22,596,229	$20,754,375	$20,532,838
Basic Average Shares	$26,084,709	$22,596,229	$20,754,375	$20,532,838
Diluted NI Availto Com Stockholders	$-53,306,000	$-59,965,000	$-41,199,000	$-41,428,000
Tax Provision	$-18,000	$55,000	$147,000	$109,000
Research And Development	$11,132,000	$11,131,000	$11,633,000	$9,952,000
Selling General And Administration	$88,473,000	$91,317,000	$64,509,000	$50,045,000

Fetched: 2026-06-11

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$39,324,000	$71,055,000	$75,947,000	$109,180,000
Total Assets	$104,794,000	$133,414,000	$115,229,000	$124,937,000
Total Non Current Assets	$3,147,000	$3,601,000	$3,139,000	$2,059,000
Other Non Current Assets	$26,000	$27,000	$27,000	$27,000
Current Assets	$101,647,000	$129,813,000	$112,090,000	$122,878,000
Other Current Assets	$3,069,000	$2,505,000	$2,987,000	$4,223,000
Inventory	$12,205,000	$12,107,000	$10,983,000	$6,957,000
Receivables	$10,665,000	$9,268,000	$7,551,000	$5,504,000
Accounts Receivable	$10,665,000	$9,268,000	$7,551,000	$5,504,000
Allowance For Doubtful Accounts Receivable	$-871,000	$-780,000	$-508,000	$-679,000
Gross Accounts Receivable	$11,536,000	$10,048,000	$8,059,000	$6,183,000
Cash Cash Equivalents And Short Term Investments	$75,708,000	$105,933,000	$90,569,000	$106,194,000
Cash And Cash Equivalents	$75,708,000	$105,933,000	$90,569,000	$106,194,000
Prepaid Assets	-	-	-	-
Debt
Total Debt	$50,504,000	$50,432,000	$30,613,000	$7,086,000
Long Term Debt And Capital Lease Obligation	$50,152,000	$50,150,000	$30,382,000	$6,864,000
Long Term Debt	$49,514,000	$49,273,000	$29,222,000	$6,747,000
Current Debt And Capital Lease Obligation	$352,000	$282,000	$231,000	$222,000
Liabilities
Total Liabilities Net Minority Interest	$65,470,000	$62,359,000	$39,282,000	$15,757,000
Total Non Current Liabilities Net Minority Interest	$52,153,000	$51,597,000	$31,418,000	$7,669,000
Other Non Current Liabilities	$2,001,000	$1,447,000	$1,036,000	$805,000
Current Liabilities	$13,317,000	$10,762,000	$7,864,000	$8,088,000
Payables And Accrued Expenses	$5,999,000	$4,806,000	$3,528,000	$4,603,000
Interest Payable	$403,000	$437,000	$220,000	-
Payables	$3,926,000	$2,717,000	$2,009,000	$1,839,000
Total Tax Payable	$93,000	$135,000	$125,000	$120,000
Accounts Payable	$3,833,000	$2,582,000	$1,884,000	$1,719,000
Equity
Common Stock Equity	$39,324,000	$71,055,000	$75,947,000	$109,180,000
Total Equity Gross Minority Interest	$39,324,000	$71,055,000	$75,947,000	$109,180,000
Stockholders Equity	$39,324,000	$71,055,000	$75,947,000	$109,180,000
Gains Losses Not Affecting Retained Earnings	$-203,000	$-206,000	$-207,000	$-207,000
Other Equity Adjustments	$-203,000	$-206,000	$-207,000	$-207,000
Retained Earnings	$-590,652,000	$-537,346,000	$-477,381,000	$-436,182,000
Preferred Securities Outside Stock Equity	-	-	-	-
Other
Ordinary Shares Number	$26,311,607	$25,324,684	$20,879,199	$20,633,736
Share Issued	$26,311,607	$25,324,684	$20,879,199	$20,633,736
Tangible Book Value	$39,324,000	$71,055,000	$75,947,000	$109,180,000
Invested Capital	$88,838,000	$120,328,000	$105,169,000	$115,927,000
Working Capital	$88,330,000	$119,051,000	$104,226,000	$114,790,000
Capital Lease Obligations	$990,000	$1,159,000	$1,391,000	$339,000
Total Capitalization	$88,838,000	$120,328,000	$105,169,000	$115,927,000
Additional Paid In Capital	$629,916,000	$608,354,000	$553,326,000	$545,362,000
Capital Stock	$263,000	$253,000	$209,000	$207,000
Common Stock	$263,000	$253,000	$209,000	$207,000
Long Term Capital Lease Obligation	$638,000	$877,000	$1,160,000	$117,000
Current Capital Lease Obligation	$352,000	$282,000	$231,000	$222,000
Pensionand Other Post Retirement Benefit Plans Current	$6,966,000	$5,674,000	$4,105,000	$3,263,000
Current Accrued Expenses	$2,073,000	$2,089,000	$1,519,000	$2,764,000
Net PPE	$3,121,000	$3,574,000	$3,112,000	$2,032,000
Accumulated Depreciation	$-4,148,000	$-3,407,000	$-2,788,000	$-2,280,000
Gross PPE	$7,269,000	$6,981,000	$5,900,000	$4,312,000
Leases	$827,000	$542,000	$98,000	$95,000
Construction In Progress	$325,000	$720,000	$554,000	$231,000
Other Properties	$4,411,000	$4,213,000	$4,070,000	$3,018,000
Machinery Furniture Equipment	$1,706,000	$1,506,000	$1,178,000	$968,000
Properties	$0	$0	$0	$0
Finished Goods	$3,104,000	$4,897,000	$5,615,000	$3,534,000
Work In Process	$473,000	$353,000	$654,000	$1,033,000
Raw Materials	$8,628,000	$6,857,000	$4,714,000	$2,390,000
Treasury Shares Number	-	-	$0	-

Fetched: 2026-06-11

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-40,750,000	$-40,505,000	$-39,612,000	$-43,362,000
Operating Activities
Operating Cash Flow	$-40,170,000	$-39,144,000	$-39,021,000	$-42,677,000
Cash Flow From Continuing Operating Activities	$-40,170,000	$-39,144,000	$-39,021,000	$-42,677,000
Operating Gains Losses	$86,000	-	$4,000	-
Investing Activities
Capital Expenditure	$-580,000	$-1,361,000	$-591,000	$-685,000
Investing Cash Flow	$-580,000	$-1,361,000	$-591,000	$-685,000
Cash Flow From Continuing Investing Activities	$-580,000	$-1,361,000	$-591,000	$-685,000
Financing Activities
Issuance Of Capital Stock	$8,974,000	$32,521,000	$0	$0
Financing Cash Flow	$10,520,000	$55,870,000	$23,984,000	$7,493,000
Cash Flow From Continuing Financing Activities	$10,520,000	$55,870,000	$23,984,000	$7,493,000
Net Common Stock Issuance	$8,974,000	$32,521,000	$0	$0
Common Stock Issuance	$8,974,000	$32,521,000	$0	$0
Net Other Financing Charges	-	$-152,000	$-179,000	$-778,000
Repurchase Of Capital Stock	-	-	-	$0
Net Preferred Stock Issuance	-	-	-	-
Preferred Stock Issuance	-	-	-	-
Other
Issuance Of Debt	$0	$20,000,000	$22,500,000	$7,500,000
Interest Paid Supplemental Data	$5,045,000	$3,614,000	$1,396,000	$59,000
End Cash Position	$75,708,000	$105,933,000	$90,569,000	$106,194,000
Beginning Cash Position	$105,933,000	$90,569,000	$106,194,000	$142,072,000
Effect Of Exchange Rate Changes	$5,000	$-1,000	$3,000	$-9,000
Changes In Cash	$-30,230,000	$15,365,000	$-15,628,000	$-35,869,000
Proceeds From Stock Option Exercised	$1,546,000	$3,501,000	$1,663,000	$771,000
Net Issuance Payments Of Debt	$0	$20,000,000	$22,500,000	$7,500,000
Net Long Term Debt Issuance	$0	$20,000,000	$22,500,000	$7,500,000
Long Term Debt Issuance	$0	$20,000,000	$22,500,000	$7,500,000
Net PPE Purchase And Sale	$-580,000	$-1,361,000	$-591,000	$-685,000
Purchase Of PPE	$-580,000	$-1,361,000	$-591,000	$-685,000
Change In Working Capital	$1,001,000	$949,000	$-4,805,000	$-5,573,000
Change In Payables And Accrued Expense	$3,039,000	$3,259,000	$-5,000	$2,082,000
Change In Accrued Expense	$1,788,000	$2,561,000	$-170,000	$873,000
Change In Payable	$1,251,000	$698,000	$165,000	$1,209,000
Change In Account Payable	$1,251,000	$698,000	$165,000	$1,209,000
Change In Prepaid Assets	$-543,000	$531,000	$1,273,000	$-1,634,000
Change In Inventory	$-98,000	$-1,124,000	$-4,026,000	$-3,077,000
Change In Receivables	$-1,397,000	$-1,717,000	$-2,047,000	$-2,944,000
Changes In Account Receivables	$-1,397,000	$-1,717,000	$-2,047,000	$-2,944,000
Other Non Cash Items	$241,000	$203,000	$154,000	$25,000
Stock Based Compensation	$11,052,000	$19,050,000	$6,303,000	$3,887,000
Depreciation Amortization Depletion	$756,000	$619,000	$522,000	$412,000
Depreciation And Amortization	$756,000	$619,000	$522,000	$412,000
Depreciation	$756,000	$619,000	$522,000	$412,000
Gain Loss On Sale Of PPE	$86,000	$0	$4,000	$0
Net Income From Continuing Operations	$-53,306,000	$-59,965,000	$-41,199,000	$-41,428,000
Income Tax Paid Supplemental Data	-	$0	$4,000	$5,000
Repayment Of Debt	-	-	-	$0
Common Stock Payments	-	-	-	$0
Long Term Debt Payments	-	-	-	$0
Gain Loss On Investment Securities	-	-	-	-

Fetched: 2026-06-11